Research and academic interests include treatment of schizophrenia, major depression, PTSD and Alzheimer's dementia. Regarding psychotropic agents, I am particularly interested in their mechanism of action, interactions, predictors of efficacy (potential biomarkers) and the strategies to treat refractory illness.